CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,952,385
- in 10 filings, $770K under 10b5-1 plans
Net −$3,952,385. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | Chudova Darya Chief Technology Officer | Exercise or conversion · Restricted Stock Units | −1,340 | 6,696 | ||
| 2025-07-01 | Chudova Darya Chief Technology Officer | Exercise or conversion · Restricted Stock Units | −1,667 | 8,337 | ||
| 2025-07-01 | Bell Michael Brian Chief Financial Officer | Exercise or conversion | +2,084 | 44,085 | ||
| 2025-07-01 | Bell Michael Brian Chief Financial Officer | Shares withheld for taxes | −1,057 | $50.71 | $54K | 43,028 |
| 2025-07-01 | Bell Michael Brian Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,084 | 10,421 | ||
| 2025-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −72,068 | $50.67 | $3.7M | 1,999,762 |
| 2025-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Sale 10b5-1 | −27,932 | $51.40 | $1.4M | 1,971,830 |
| 2025-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Exercise or conversion 10b5-1 | +23,997 | 1,995,827 | ||
| 2025-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes 10b5-1 | −12,162 | $50.71 | $617K | 1,983,665 |
| 2025-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −23,997 | 143,983 | ||
| 2025-07-01 | Eltoukhy Helmy Co-Chief Executive Officer | Exercise or conversion | +23,997 | 2,435,661 | ||
| 2025-07-01 | Eltoukhy Helmy Co-Chief Executive Officer | Shares withheld for taxes | −12,162 | $50.71 | $617K | 2,423,499 |
| 2025-07-01 | Eltoukhy Helmy Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −23,997 | 143,983 | ||
| 2025-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Exercise or conversion 10b5-1 | +4,815 | 2,074,271 | ||
| 2025-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes 10b5-1 | −2,441 | $52.04 | $127K | 2,071,830 |
| 2025-06-30 | Talasaz AmirAli Co-Chief Executive Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −4,815 | 9,629 | ||
| 2025-06-30 | Krognes Steve E. Director | Exercise or conversion | +154 | 17,819 | ||
| 2025-06-30 | Krognes Steve E. Director | Exercise or conversion · Restricted Stock Units | −154 | 1,852 | ||
| 2025-06-30 | Eltoukhy Helmy Co-Chief Executive Officer | Exercise or conversion | +4,815 | 2,414,105 | ||
| 2025-06-30 | Eltoukhy Helmy Co-Chief Executive Officer | Shares withheld for taxes | −2,441 | $52.04 | $127K | 2,411,664 |
Page 45 of 57 · 1,133 trades